Assessing cardiovascular risk in children with chronic kidney disease. B-type natriuretic peptide: A potential new marker

Pediatric Nephrology

Volumn 20, Issue 12, 2005, Pages 1701-1707

  Ariceta, Gema ^a,b   Brooks, Ellen R ^b   Langman, Craig B ^b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cardiac dysfunction; Congestive heart failure; Dialysis; Hypertension; Kidney transplant; Left ventricular hypertrophy

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ADULT; AGE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CHILDHOOD DISEASE; CHRONIC KIDNEY DISEASE; CIRCULATION; CONGENITAL HEART DISEASE; CONGESTIVE HEART FAILURE; DATA ANALYSIS; DIAGNOSTIC TEST; EVIDENCE BASED MEDICINE; FEMALE; GENDER; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEREDITY; HIGH RISK POPULATION; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MALE; MEASUREMENT; MEDICAL LITERATURE; MORBIDITY; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY FAILURE, CHRONIC; MALE; MODELS, BIOLOGICAL; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 28444476937     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-1954-1     Document Type: Review

References (72)

1. Mitsnefes MM (2002) Pediatric end-stage renal disease: Heart as target. J Pediatr 141:162-164 10.1067/mpd.2002.126921
2. The USRDS 2004 Annual Report (2004) Pediatric end-stage renal disease. http://www.usrds.org
3. Gruppen MP, Groothoff JW, Prins M, et al (2003) Cardiac disease in young adult patients with end-stage renal disease since childhood: A Dutch cohort study. Kidney Int 63:1058-1065 10.1046/j.1523-1755.2003.00814.x
4. Parekh RS, Carroll CE, Wolfe RA, Port FK (2002) Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 141:191-197 10.1067/mpd.2002.125910
5. Levin RE, Gardner DG, Samson WK (1998) Natriuretic peptides. N Engl J Med 339:321-328 10.1056/NEJM199807303390507
6. Kyuma M, Nkata T, Hshimoto A, Nagao K, Sasao H, Takahshi T, Tsuchihashi K, Shimamoto K (2004) Incremental prognosis implications of brain natriuretic peptide, cardiac sympathetic nerve innervations and noncardiac disorders in patients with heart failure. J Nucl Med 45:155-163 14960630
7. Yamamoto K, Burnet JC, Jougasaki M, Nishimura RA, Bailey KR, Saito K, Nakao K, Redfield MM (1996) Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 28:988-994 8952587
8. Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, Kangawa K, Matsuo H, Omae T, Matsuoka H (1996) Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 28:22-30 8675258
9. Nishikimi T, Futoo Y, Tamano K, Takahashi M, Suzuki T, Minami J, et al (2001) Plasma brain natriuretic peptide levels in chronic hemodialysis patients: Influence of coronary artery disease. Am J kidney Dis 37:1201-1208 11382689
10. Ishizaka Y, Yamamoto Y, Fukunaga T, et al (1994) Plasma concentration of human brain natriuretic peptide in patients on hemodialysis. Am J Kidney Dis 24:46-72
11. Westerlind A, Wahlander H, Lindstedt G, Lumberg PA, Holmgren D (2004) Clinical signs of heart failure are associated with increased levels of natriuretic peptides types B and A in children with congenital heart defects or cardiomyopathy. Acta Paediatr 93:340-345 10.1080/ 08035250410022756
12. Claudius I, Lan YT, Chang RK, Wetzel GT, Alejos J (2003) Usefulness of B-type natriuretic peptide as noninvasive screening tool for cardiac allograft pathology in pediatric heart transplant recipients. Am J Cardiol 92:1368-1370 10.1016/j.amjcard.2003.08.035
13. Ruskoaho H (2003) Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 24:341-356 10.1210/er.2003-0006
14. National Kidney Foundation Kidney Disease Outcomes Quality Initiative (2003) Clinical practice guidelines for managing dyslipidemias in chronic kidney disease. Am J Kidney Dis 41 [Suppl]:S1-S91
15. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100-105 10.1161/01.CIR.0000020222.63035.C0
16. Dhingra H, Roongsritong C, Kurtzman NA (2002) Brain natriuretic peptide: role in cardiovascular and volume homeostasis. Semin Nephrol 22:423-437 10.1053/snep.2002.35666
17. Cameron VA, Ellmers LJ (2003) Minireview: Natriuretic peptides during development of the fetal heart and circulation. Endocrinology 144:2191-2194 10.1210/en.2003-0127
18. de Lemos JA, McGuire DK, Drazner MH (2003) B-type natriuretic peptide in cardiovascular disease. Lancet 362:316-322 10.1016/S0140-6736(03)13976-1
19. Jortani SA, Prabbu SD, Valdes R (2004) Strategies for developing biomarkers of heart failure. Clin Chem 50:265-278 10.1373/ clinchem.2003.027557
20. Clerico A, Emdin M (2004) Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: A review. Clin Chem 50:33-50 10.1373/clinchem.2003.024760
21. Yoshibayashi M, Kamiya T, Saito Y, Nakao K, Nishioka K, Temma S, et al (1995) Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: Marked and rapid increase after birth. Eur J Endocrinol 133:207-209 7655645
22. Kunii Y, Kamada M, Ohtsuki S, Araki T, et al (2003) Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama 57:191-197 14627071
23. Koch A, Singer H (2003) Normal values of B type natriuretic peptide in infants, children and adolescents. Heart 89:875-878 10.1136/ heart.89.8.875
24. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC (2002) Plasma brain natriuretic peptide concentration: Impact of age and gender. J Am Coll Cardiol 40:976-982 10.1016/S0735-1097(02)02059-4
25. Wang TJ, Larson MG, Levy D, et al (2003) Heritability and genetic linkage of plasma natriuretic peptide levels. Circulation 108:13-16 10.1161/01.CIR.0000081657.83724.A7
26. Wang TJ, Larson MG, Levy D, Benjamin EJ, Corey D, Leip EP, et al (2004) Impact of obesity on plasma natriuretic peptide levels. Circulation 109:595-600
27. McCullough PA, Sandberg KR (2003) Sorting out the evidence on natriuretic peptides. Rev Cardiovasc Med 4[Suppl 4]: S13-S19
28. Nakatami T, Nagamuna T, Masuda C, Uchida J, Sugimura T, Sugimura K (2002) Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis. Int J Mol Med 10:457-461 12239593
29. Naganuma T, Sugimura K, Wada S, et al (2002) The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol 22:437-444 10.1159/000065272
30. Takami Y, Horio T, Iwashima Y, Takiuchi S, Kamide K, Yoshihara F, et al (2004) Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Am J Kidney Dis 44:420 15332214
31. Yano Y, Katsuki A, Gabazza EC, Ito K, Fujii M, Furuta M, et al (1999) Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria. J Clin Endocrinol Metab 84:2353-2356 10.1210/jc.84.7.2353
32. Biosite (2002) TriageBNP package insert. Biosite, San Diego
33. McCullough PA, Duc P, Omland T, et al (2003) B-type natriuretic peptide and renal function in the diagnosis of heart failure: An analysis from the breathing not properly multinational study. Am J Kidney Dis 41:571-579 10.1053/ajkd.2003.50118
34. Ishii J, Cui W, Kitagawa F, et al (2003) Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure. Clin Chem 49:2020-2026 10.1373/clinchem.2003.021311
35. Bruins S, Fokkema MR. Romer JWP, et al (2004) High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 50:2052-2058 10.1373/clinchem.2004.038752
36. Kurotobi S, Kawakami N, Shimizu K, et al (2005) Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki Disease. Pediatr Cardiol, Han 13, Epub ahead of print
37. Suda K, Matsumura M, Matsumoto M. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 45:249-254
38. Lan YT, Chang RKR, Alejos JC, Burch C, Wetzel GT (2004) B-type natriuretic peptide in children after cardiac transplantation. J Heart Lung Transplant 23:558-563 10.1016/S1053-2498(03)00306-1
39. Kario K, Nishikimi T, Toshikaara F, Takishita S, Yamakoa R, Matsuo T, Matuso H, Mithuhashi T, Shimada K, Kangawa K (1998) Plasma levels of natriuretic peptides and adrenomedullin in elderly hypertensive patients: Relationships to 24 h blood pressure. J Hypertens 16:1253-1259 10.1097/00004872-199816090-00005
40. Hoshide S, Kario K, Hoshide Y, Umeda Y, Hashimoto T, Kunii O, Ojima T, Shimada K (2003) Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens 16:434-438 10.1016/S0895-7061(03)00567-3
41. Kato J, Kitamura K, Uemura T, et al (2002) Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: Their relations to age and pulse pressure. Hypertens Res 25:887-892 10.1291/hypres.25.887
42. Freitag MH, Laron MG, Levy D, Benjamin EJ, et al (2003) Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart Study. Hypertension 41:978-983 10.1161/01.HYP.0000061116.20490.8D
43. Mussalo H, Vanninen E, Ikäheimo R, Hartikainen J (2003) NT-proANP and BNP in renovascular and in severe and mild essential hypertension. Kidney Blood Press Res 26:34-41
44. Suzuki M, Hamada M, Yamamoto K, Kazatani Y, Hiwada K (2002) Brain natriuretic peptide as a risk marker for incident hypertensive cardiovascular events. Hypertens Res 25:669-676 10.1291/hypres.25.669
45. Grandi AM, Laurita E, Selva E, Piantanida E, Imperiale D, Giovanella L, et al (2004) Natriuretic peptides as markers of preclinical cardiac disease in obesity. Eur J Clin Invest 34:342-348 10.1111/ j.1365-2362.2004.01348.x
46. Lee SW, Song JH, Kim GA, Lim HJ, Kim MJ (2003) Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. Am J Kidney Dis 41:1257-1266 10.1016/S0272-6386(03)00358-5
47. Cataliotti A, Malatino LS, Jougasaki M, et al (2001) Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc 76:1111-1119 11702899
48. Goto T, Takase H, Toriyama T, et al (2002) Increased circulating levels of natriuretic peptides predict future cardiac event in patients with chronic hemodialysis. Nephron 92:610-615 10.1159/000064100
49. Naganuma T, Sugimura K, Wada S, et al (2002) The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol 22:437-444 10.1159/000065272
50. McCullough PA, Joseph K, Mathur VS (2004) Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. Rev Cardiovasc Med 5:16-25 15029111
51. Groothoff J, Gruppen M, Offringa M, De Groot E, Stok W, Bos W, Davin J, Lilien M, Van De Kar N, Woff E, Heymans H (2002) Increased arterial stiffness in young adults with end-stage renal disease since childhood. J Am Soc Nephrol 13:2953-2961 10.1097/01.ASN.0000037677.16961.DF
52. Mitsnefes MM, Daniels SR, Scwartz SM, Meyer RA, Khoury P, Strife CF (2000) Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 14:898-902 10.1007/ s004670000303
53. Nayir A, Bilge I, Kilicaslan I, Ander H, Emre S, Sirin A (2001) Arterial changes in paediatric haemodialysis patients undergoing renal transplantation. Nephrol Dial Transplant 16:2041-2047 10.1093/ndt/ 16.10.2041
54. Goodman W, Goldin J, Kuizon B, Chun Y, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff R, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Eng J Med 342:1478-1483 10.1056/ NEJM200005183422003
55. Silverstein D, Palmer J, Polinsky M, Braas C, Conley S, Baluarte H (2000) Risk factors for hyperlipidemia in long-term pediatric transplant recipients. Pediatr Nephrol 14:105-110 10.1007/s004670050022
56. Jacobson SH, Egverg N, Hylander B, Lundahl J (2002) Correlation between soluble markers of endothelial dysfunction in patients with chronic renal failure. Am J Nephrol 22:42-47 10.1159/000046673
57. Zoccali C, Benedetto FA, Mallamaci F, Tripipi G, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Nicocia G, Buemi M (2003) Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure. Eur J Clin Invest 33:561-566 10.1046/j.1365-2362.2003.01169.x
58. Turi S, Friedman A, Bereczki C, Papp F, Kovacs J, Karg E, Nemeth I (2003) Oxidative stress in juvenile essential hypertension. J Hypertens 21:145-152 10.1097/00004872-200301000-00024
59. Aggoun Y, Niaudet P, Laffont A, Sidi D, Kachaner J, Bonnet D (2000) Cardiovascular impact of end-stage renal insufficiency. Arch Mal Coeur Vaiss 93:1009-1013 10989747
60. Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2003) Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 107:864-868 10.1161/ 01.CIR.0000049744.23613.69
61. Ma KK, Ogawa T, de Bold AJ (2004) Selective upregulation of cardiac brain natriuretic peptide at the transcriptional levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 36:505-513 10.1016/j.yjmcc.2004.01.001
62. Nishimura M, Hashimoto T, Kobayashi H, et al (2003) Possible involvement of TNF-alpha in left ventricular remodeling in hemodialysis patients. J Nephrol 16:641-649 14733409
63. Mitsnefes MM, Kimball TR, Daniels SR (2003) Office and ambulatory blood pressure elevation in children with chronic renal failure. Pediatr Nephrol 18:145-149 12579404
64. Lingens N, Dobos E, Witte K, Busch C, Lemmer B, Klaus G, Scharer K (1997) Twenty-four-hour ambulatory blood pressure profiles in pediatric patients after renal transplantation. Pediatr Nephrol 11:23-26 10.1007/ s004670050226
65. Node K, Fujit M, Kitakaze M, Hori M, Liao JK (2003) Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation 108:839-843 10.1161/ 01.CIR.0000084539.58092.DE
66. Sanjad S, Al-Abbad A, Al-Shorafa S (1997) Management of hyperlipidemia in children with refractory nephritic syndrome: The effect of statin therapy. J Pediatr 130:470-474 9063427
67. Argent E, Kainer G, Aitken M, Rosenberg AR, Mackie F (2003) Atorvastatin treatment for hyperlipidemia in pediatric renal transplant recipients. Pediatr Transplant 7:38-42 10.1034/j.1399-3046.2003.02048.x
68. Chong AY, Blann AD, Patel J, Freestone B, Hughes E, Lip GYH (2004) Endothelial dysfunction and damage in congestive heart failure. Relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage and brain natriuretic peptide. Circulation 110:1794-1798 10.1161/01.CIR.0000143073.60937.50
69. Cheng V, Kazanagra R, Garcia A, et al (2001) A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study. J Am Coll Cardiol 37:386-391 10.1016/S0735-1097(00)01157-8
70. Yokota N, Yamamoto Y, Aburaya N, Kitamura K, Eto T, Kangawa K, et al (1991) Increased secretion of brain natriuretic peptide and atrial natriuretic peptide, but not sufficient to induce natriuresis in rats with nephrotic syndrome. Biochem Biophys Res Commun 174:128-135 10.1016/ 0006-291X(91)90495-S
71. Mallamaci F, Zoccali C, Tripeti, et al (2001) Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 59:1559-1566 10.1046/j.1523-1755.2001.0590041559.x
72. Zoccali C, Mallamaci F, Benedetto, et al (2001) Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 12:1508-1515 11423580